99207-271 : Zyclara 37.5 mg/g Topical Cream


NDC99207-271
Labeler: Medicis Pharmaceutical Corp
Product Type: Human Prescription Drug
Drug Name:  Zyclara
Dosage Form: Topical Cream
Application #: NDA022483
Rev. Date: 


NDC Package Codes:

  • 99207-271-01: 1 BOTTLE, PUMP IN 1 CARTON (99207‑271‑01) > 7.5 G IN 1 BOTTLE, PUMP
  • 99207-271-75: 1 BOTTLE, PUMP IN 1 CARTON (99207‑271‑75) > 7.5 G IN 1 BOTTLE, PUMP

Active Ingredients:

  • Imiquimod

Dosage Strength:

  • 37.5 mg/g

Pharmaceutical Classes:

  • Increased Cytokine Activity [PE]
  • Increased Cytokine Production [PE]
  • Interferon Inducers [MoA]

Related Products:

Based on records with the same trade name.
  • 99207-270 Zyclara 37.5 mg/g Topical Cream by Medicis Pharmaceutical Corp
  • 99207-276 Zyclara 2.5 mg/g Topical Cream by Medicis Pharmaceutical Corp
  • 29336-710 Zyclara 3.75 mg/100mg Topical Cream by Graceway Pharmaceuticals, LLC
  • 29336-750 Zyclara 3.75 mg/100mg Topical Cream by Graceway Pharmaceuticals, LLC
  • 29336-910 Zyclara 2.5 mg/100mg Topical Cream by Graceway Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 99207-271 QR Code

< Prev: 99207-270Next: 99207-276 >

Related Discussions:

Aldara (imiquimod)
Topical anti-tumor medication ## What is aldara used for? What are the side effects? ## My GP is pressuring me to use Al... 2 replies
Zyclara Reviews
I used Zyclara as directed for 2 weeks, the last 4 or 5 days on my cheeks. It peeled as I expected but left some scaring... 3 replies
Zyclara usage
Can Zyclara face cream be used for 8 hours during the day instead of using it overnight? Trying to sleep with it on my f... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.